Published in Kidney Int on November 01, 2005
Key roles of adjuvants in modern vaccines. Nat Med (2013) 2.62
TLR-based immune adjuvants. Vaccine (2010) 2.10
Vaccination in elite athletes. Sports Med (2014) 1.50
Unleashing the potential of NOD- and Toll-like agonists as vaccine adjuvants. Proc Natl Acad Sci U S A (2014) 1.36
Vaccine Adjuvants: from 1920 to 2015 and Beyond. Vaccines (Basel) (2015) 0.99
Immunogenomics and systems biology of vaccines. Immunol Rev (2011) 0.97
Immunogenicity and safety of Advax™, a novel polysaccharide adjuvant based on delta inulin, when formulated with hepatitis B surface antigen: a randomized controlled Phase 1 study. Vaccine (2014) 0.95
Strategies to increase responsiveness to hepatitis B vaccination in adults with HIV-1. Lancet Infect Dis (2012) 0.95
Hepatitis B virus and Homo sapiens proteome-wide analysis: A profusion of viral peptide overlaps in neuron-specific human proteins. Biologics (2010) 0.92
Carbohydrate-based immune adjuvants. Expert Rev Vaccines (2011) 0.90
Next Generation Cancer Protection: The Bivalent HPV Vaccine for Females. ISRN Obstet Gynecol (2011) 0.89
Immunization with the Haemophilus ducreyi hemoglobin receptor HgbA with adjuvant monophosphoryl lipid A protects swine from a homologous but not a heterologous challenge. Infect Immun (2010) 0.89
The duration of hepatitis B vaccine immunity in pediatric dialysis patients. Pediatr Nephrol (2014) 0.87
The potential of 1018 ISS adjuvant in hepatitis B vaccines: HEPLISAV™ review. Hum Vaccin Immunother (2013) 0.85
Immune Adjuvant Effect of Molecularly-defined Toll-Like Receptor Ligands. Vaccines (Basel) (2014) 0.84
Unsolved problems and future perspectives of hepatitis B virus vaccination. World J Gastroenterol (2015) 0.84
Factors affecting effectiveness of vaccination against hepatitis B virus in hemodialysis patients. World J Gastroenterol (2014) 0.82
Temporal Characteristics of the Sleep EEG Power Spectrum in Critically Ill Children. J Clin Sleep Med (2015) 0.80
Comparative Safety of Vaccine Adjuvants: A Summary of Current Evidence and Future Needs. Drug Saf (2015) 0.79
Identification, investigation and management of patient-to-patient hepatitis B transmission within an inpatient renal ward in North West England. Clin Kidney J (2014) 0.79
Modulation of gene expression related to Toll-like receptor signaling in dendritic cells by poly(gamma-glutamic acid) nanoparticles. Clin Vaccine Immunol (2010) 0.79
Cationic lipid-formulated DNA vaccine against hepatitis B virus: immunogenicity of MIDGE-Th1 vectors encoding small and large surface antigen in comparison to a licensed protein vaccine. PLoS One (2014) 0.79
Safety and immunogenicity of an investigational adjuvanted hepatitis B vaccine (HB-AS02V) in healthy adults. Hum Vaccin (2010) 0.76
Improving hepatitis B vaccine efficacy in end-stage renal diseases patients and role of adjuvants. ISRN Gastroenterol (2012) 0.76
Immunizations in children with chronic kidney disease. Pediatr Nephrol (2011) 0.76
Immunogenicity and immunization costs of adjuvanted versus non-adjuvanted hepatitis B vaccine in chronic kidney disease patients. Hum Vaccin Immunother (2016) 0.75
A randomized pilot trial on the effect of granulocyte-colony stimulating factor on antibody response in hemodialysis patients who had not responded to routine hepatitis B virus vaccine. J Nephropathol (2015) 0.75
From discovery to licensure, the Adjuvant System story. Hum Vaccin Immunother (2016) 0.75
Enhancing the work of the Department of Health and Human Services national vaccine program in global immunization: recommendations of the National Vaccine Advisory Committee: approved by the National Vaccine Advisory Committee on September 12, 2013. Public Health Rep (2014) 0.75
Variability in response to hepatitis B vaccine in hemodialysis patients. J Clin Med Res (2015) 0.75
Decreasing High Failure Rate of Vaccinations in Patients With Chronic Kidney Disease; not Just a Matter of Quantity. Hepat Mon (2012) 0.75
Targeting Pattern Recognition Receptors (PRR) for Vaccine Adjuvantation: From Synthetic PRR Agonists to the Potential of Defective Interfering Particles of Viruses. Viruses (2017) 0.75
Dendritic Cell Dysfunction in Patients with End-stage Renal Disease. Immune Netw (2017) 0.75
The accelerated hepatitis B virus vaccination schedule among hemodialysis patients, does it work? A randomized controlled trial. J Nephrol (2017) 0.75
Ensembl 2009. Nucleic Acids Res (2008) 25.38
Ensembl 2007. Nucleic Acids Res (2006) 20.10
First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children. N Engl J Med (2011) 10.79
Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age. N Engl J Med (2008) 7.28
Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection. J Infect Dis (2009) 6.90
A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants. N Engl J Med (2012) 6.64
Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trial. Lancet (2007) 4.83
Safety and immunogenicity of RTS,S/AS02D malaria vaccine in infants. N Engl J Med (2008) 4.35
Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: a randomised controlled trial. Lancet Infect Dis (2011) 2.79
Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial. Lancet Infect Dis (2011) 2.54
Long-term safety and efficacy of the RTS,S/AS02A malaria vaccine in Mozambican children. J Infect Dis (2009) 2.36
Four-year efficacy of RTS,S/AS01E and its interaction with malaria exposure. N Engl J Med (2013) 2.24
Screening for mutations related to atovaquone/proguanil resistance in treatment failures and other imported isolates of Plasmodium falciparum in Europe. J Infect Dis (2004) 1.99
AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial. Lancet Infect Dis (2013) 1.95
Occult hepatitis C virus infection among hemodialysis patients. J Am Soc Nephrol (2008) 1.90
Incomplete surveillance of a dengue-2 epidemic in Ibagué, Colombia, 1995-1997. Biomedica (2004) 1.70
The low and declining risk of malaria in travellers to Latin America: is there still an indication for chemoprophylaxis? Malar J (2007) 1.69
Evaluation of RTS,S/AS02A and RTS,S/AS01B in adults in a high malaria transmission area. PLoS One (2009) 1.66
Randomized controlled trial of RTS,S/AS02D and RTS,S/AS01E malaria candidate vaccines given according to different schedules in Ghanaian children. PLoS One (2009) 1.65
RTS,S/AS02A malaria vaccine does not induce parasite CSP T cell epitope selection and reduces multiplicity of infection. PLoS Clin Trials (2006) 1.65
Insights into long-lasting protection induced by RTS,S/AS02A malaria vaccine: further results from a phase IIb trial in Mozambican children. PLoS One (2009) 1.64
[Prevalence of infection by carbapenem-resistant Acinetobacter baumannii in Spain (1999-2005)]. Enferm Infecc Microbiol Clin (2008) 1.52
Response to an experimental HBV vaccine permits withdrawal of HBIg prophylaxis in fulminant and selected chronic HBV-infected liver graft recipients. Liver Transpl (2005) 1.52
A randomized controlled trial of nurses vs. doctors in the resolution of acute disease of low complexity in primary care. J Adv Nurs (2013) 1.47
[Similarities and differences among patients with symptomatic atherosclerosis affecting several territories. The AIRVAG cohort (Integral Attention to Global VAscular Risk)]. Med Clin (Barc) (2006) 1.43
Circumsporozoite-specific T cell responses in children vaccinated with RTS,S/AS01E and protection against P falciparum clinical malaria. PLoS One (2011) 1.43
Multidisciplinary approach and multimodal therapy in resected pancreatic cancer. Observational study. Rev Esp Enferm Dig (2011) 1.41
[Persistent polyclonal B-cell lymphocytosis: study of 35 cases]. Med Clin (Barc) (2011) 1.38
[Susceptibility to measles, rubella and parotitis in young adults]. Med Clin (Barc) (1996) 1.38
A randomized trial assessing the safety and immunogenicity of AS01 and AS02 adjuvanted RTS,S malaria vaccine candidates in children in Gabon. PLoS One (2009) 1.31
Effect of the pre-erythrocytic candidate malaria vaccine RTS,S/AS01E on blood stage immunity in young children. J Infect Dis (2011) 1.28
Impact of RTS,S/AS02(A) and RTS,S/AS01(B) on genotypes of P. falciparum in adults participating in a malaria vaccine clinical trial. PLoS One (2009) 1.26
Bile-duct hamartomas presenting as multiple focal lesions on hepatic ultrasonography. Am J Gastroenterol (1992) 1.26
Evaluation of the safety and immunogenicity of the RTS,S/AS01E malaria candidate vaccine when integrated in the expanded program of immunization. J Infect Dis (2010) 1.21
Nummular headache: a prospective series of 14 new cases. Headache (2004) 1.18
Rapid and differential diagnosis of foot-and-mouth disease, swine vesicular disease, and vesicular stomatitis by a new multiplex RT-PCR assay. J Virol Methods (2007) 1.14
Prevalence and factors associated with the presence of nonalcoholic fatty liver disease in an adult population in Spain. Eur J Gastroenterol Hepatol (2010) 1.12
Design of a phase III multicenter trial to evaluate the efficacy of the RTS,S/AS01 malaria vaccine in children across diverse transmission settings in Africa. Malar J (2011) 1.11
RYBP represses endogenous retroviruses and preimplantation- and germ line-specific genes in mouse embryonic stem cells. Mol Cell Biol (2012) 1.08
Serological evidence of discrete spatial clusters of Plasmodium falciparum parasites. PLoS One (2011) 1.08
Four year immunogenicity of the RTS,S/AS02(A) malaria vaccine in Mozambican children during a phase IIb trial. Vaccine (2011) 1.07
Safety of the RTS,S/AS02A malaria vaccine in Mozambican children during a Phase IIb trial. Vaccine (2007) 1.05
Induction of Plasmodium falciparum-specific CD4+ T cells and memory B cells in Gabonese children vaccinated with RTS,S/AS01(E) and RTS,S/AS02(D). PLoS One (2011) 1.04
Molecular surveillance of drug resistance through imported isolates of Plasmodium falciparum in Europe. Malar J (2002) 1.04
Transvaginal liver resection (NOTES) combined with minilaparoscopy. Rev Esp Enferm Dig (2008) 1.04
A new adjuvant improves the immune response to hepatitis B vaccine in hemodialysis patients. Kidney Int (2007) 1.03
Five-year safety and immunogenicity of GlaxoSmithKline's candidate malaria vaccine RTS,S/AS02 following administration to semi-immune adult men living in a malaria-endemic region of The Gambia. Hum Vaccin (2009) 1.01
Development and technical and clinical validation of a quantitative enzyme-linked immunosorbent assay for the detection of human antibodies to hepatitis B surface antigen in recipients of recombinant hepatitis B virus vaccine. Clin Vaccine Immunol (2009) 1.00
Trends in the prevalence of pathogens causing urethritis in Asturias, Spain, 1989-2000. Sex Transm Dis (2003) 0.99
Safety, immunogenicity and duration of protection of the RTS,S/AS02(D) malaria vaccine: one year follow-up of a randomized controlled phase I/IIb trial. PLoS One (2010) 0.99
Hemosuccus pancreaticus from a pseudoaneurysm of the hepatic artery proper in a patient with a pancreatic pseudocyst. Hepatogastroenterology (1992) 0.98
A two-phase case-control study for colorectal cancer genetic susceptibility: candidate genes from chromosomal regions 9q22 and 3q22. Br J Cancer (2011) 0.97
Immunogenicity and reactogenicity of the adult tetanus-diphtheria vaccine. How many doses are necessary? Epidemiol Infect (2001) 0.96
Acute liver failure due to non-Hodgkin's lymphoma. Am J Gastroenterol (1993) 0.95
Randomized, controlled trial of the long term safety, immunogenicity and efficacy of RTS,S/AS02(D) malaria vaccine in infants living in a malaria-endemic region. Malar J (2013) 0.94
Safety of the malaria vaccine candidate, RTS,S/AS01E in 5 to 17 month old Kenyan and Tanzanian Children. PLoS One (2010) 0.94
Laccases of Pleurotus ostreatus observed at different phases of its growth in submerged fermentation: production of a novel laccase isoform. Mycol Res (2008) 0.93
Homeotic transformations of the axial skeleton of YY1 mutant mice and genetic interaction with the Polycomb group gene Ring1/Ring1A. Mech Dev (2006) 0.91
Hepatitis A vaccine: indirect evidence of immune memory 12 years after the primary course. J Med Virol (2004) 0.90
Influenza symptoms and their impact on elderly adults: randomised trial of AS03-adjuvanted or non-adjuvanted inactivated trivalent seasonal influenza vaccines. Influenza Other Respir Viruses (2014) 0.90
Short report: neonatal screening pilot study of Toxoplasma gondii congenital infection in Mexico. Am J Trop Med Hyg (2005) 0.90
Disulfiram-induced hepatitis. Report of four cases and review of the literature. J Hepatol (1994) 0.89
Characterization of the biology and infectivity of Leishmania infantum viscerotropic and dermotropic strains isolated from HIV+ and HIV- patients in the murine model of visceral leishmaniasis. Parasit Vectors (2013) 0.89
Idiopathic hypertrophic cranial pachymeningitis associated with Sweet's Syndrome. Eur J Radiol (2002) 0.89
Human Staufen1 protein interacts with influenza virus ribonucleoproteins and is required for efficient virus multiplication. J Virol (2010) 0.88
Clinical evaluation of a polygeline-free tick-borne encephalitis vaccine for adolescents and adults. Vaccine (2003) 0.88
Immunogenicity of Twinrix in older adults: a critical analysis. Expert Rev Vaccines (2003) 0.88
Clinical relevance of mixed respiratory viral infections in adults with influenza A H1N1. Eur Respir J (2011) 0.88
[Imported malaria and HIV infection in Madrid. Clinical and epidemiological features]. Rev Clin Esp (2011) 0.87
Microwave treatment of serum facilitates detection of hepatitis B virus DNA by the polymerase chain reaction. Results of a study in anti-HBe positive chronic hepatitis B. J Hepatol (1995) 0.87
Evaluation of the immune response to RTS,S/AS01 and RTS,S/AS02 adjuvanted vaccines: randomized, double-blind study in malaria-naïve adults. Hum Vaccin Immunother (2014) 0.87
Use of real-time polymerase chain reaction (rtPCR) as a diagnostic tool for influenza infection in a vaccine efficacy trial. J Clin Virol (2011) 0.86
Glycemic and lipid control in hospitalized type 2 diabetic patients: evaluation of 2 enteral nutrition formulas (low carbohydrate-high monounsaturated fat vs high carbohydrate). JPEN J Parenter Enteral Nutr (2005) 0.86
Anaphylactic reaction to ethanolamine oleate injection in sclerotherapy of esophageal varices. Endoscopy (1989) 0.86
Proteinase K enhanced immunoreactivity of the prion protein-specific monoclonal antibody 2A11. Neurosci Res (2004) 0.86
Influenza A H1N1 in HIV-infected adults. HIV Med (2011) 0.85
Pneumonia in ventilated head trauma patients: the role of thiopental therapy. Eur J Emerg Med (1995) 0.85
Molluscum contagiosum: A 20-year study in a sexually transmitted infections unit. Sex Transm Dis (2010) 0.85
Hepatitis B vaccination results in 140 liver transplant recipients. Hepatogastroenterology (1997) 0.85
[Transvaginal cholecystectomy (NOTES) combined with minilaparoscopy]. Rev Esp Enferm Dig (2007) 0.84
[The operon: a group of genes with expression coordinated by an operator. C.R.Acad. Sci. Paris 250 (1960) 1727-1729]. C R Biol (2005) 0.84
Persistence of antibodies after vaccination against tick-borne encephalitis. Int J Med Microbiol (2006) 0.83
Hepatitis B vaccination in infants of mothers infected with human immunodeficiency virus. J Med Virol (1995) 0.83
Vaccination coverage in adults undergoing splenectomy: evaluation of hospital vaccination policies. Epidemiol Infect (2005) 0.83
Incidence of respiratory viruses among travelers with a febrile syndrome returning from tropical and subtropical areas. J Med Virol (2008) 0.83
Phthirus pubis in a sexually transmitted diseases unit: a study of 14 years. Sex Transm Dis (2003) 0.83
Immunogenicity and reactogenicity of a combined hepatitis A and B vaccine in young adults. Vaccine (1996) 0.82
Antibody persistence and immune memory elicited by combined hepatitis A and B vaccination in older adults. Vaccine (2006) 0.81
Immune response of HLA DQ2 positive subjects, vaccinated with HBsAg/AS04, a hepatitis B vaccine with a novel adjuvant. Vaccine (2002) 0.81
[Underrecognized peripheral arterial disease in patients with acute coronary syndrome: prevalence of traditional and emergent cardiovascular risk factors]. Rev Esp Cardiol (2005) 0.81
Accelerated vaccination schedules provide protection against hepatitis A and B in last-minute travelers. J Travel Med (2004) 0.80
[Imported malaria in adults. Clinical, epidemiological and analytical features]. Rev Clin Esp (2011) 0.80
Diarrhea outbreak among Czech Army Field Hospital personnel caused by Providencia alcalifaciens. J Travel Med (2002) 0.80
Effect of substrate particle size and additional nitrogen source on production of lignocellulolytic enzymes by Pleurotus ostreatus strains. Bioresour Technol (2008) 0.80
[The vaccination of medical and nursing students against hepatitis B]. Med Clin (Barc) (1993) 0.80